Literature DB >> 8959659

In vitro susceptibility of Mycoplasma hyosynoviae and M. hyorhinis to antimicrobial agents.

H Kobayashi1, N Sonmez, T Morozumi, K Mitani, N Ito, H Shiono, K Yamamoto.   

Abstract

Fifty-four Japanese strains of Mycoplasma hyosynoviae isolated from porkers during 1980 to 1995, and 107 Japanese strains of M. hyorhinis isolated from piglets with respiratory disease during 1991 to 1994 were investigated for the in vitro activities of 13 antimicrobial agents [josamycin, tylosin, spiramycin, kitasamycin, erythromycin, lincomycin (LCM), kanamycin (KM), chloramphenicol (CP), thiamphenicol (TP), tiamulin (TML), oxytetracycline (OTC), chlortetracycline (CTC), and enrofloxacin (ERFX)] by the agar dilution method. Of the drugs tested TML showed the highest activity with minimum inhibitory concentration (MIC) of 0.013 to 0.1 microgram/ m/ (MIC90; 0.05 microgram/ml) against strains of M. hyosynoviae, and 0.2 to 0.78 microgram/ml (MIC90; 0.39 microgram/ml) against strains of M. hyorhinis. ERFX, LCM, most of the 16-membered macrolide antibiotics and tetracyclines also showed low MICs against both mycoplasma species. The susceptibility of KM, CP and TP to the mycoplasmas was considered to be of a secondary grade. Two of 54 strains of M. hyosynoviae, and 11 of 107 strains of M. hyorhinis showed resistance to all 14- and 16-membered macrolide antibiotics tested. Tetracyclines (OTC and CTC) showed a relatively broad MIC distribution from 0.1 to 6.25 micrograms/ml against the M. hyosynoviae strains tested. All of the strains isolated during 1980 to 1984 were susceptible at the concentration of 0.78 microgram/ml or less (MIC90; 0.78 microgram/ml) to OTC and 1.56 micrograms/ml or less (MIC90; 1.56 micrograms/ml) to CTC, while the susceptibility of strains isolated recently, during 1994 to 1995, was more than 0.78 microgram/ml (MIC90; 3.13 micrograms/ml) to OTC, and more than 1.56 micrograms/ml (MIC90; 6.25 micrograms/ml) to CTC.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8959659     DOI: 10.1292/jvms.58.11_1107

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  5 in total

1.  In vitro susceptibilities of Mycoplasma hyopneumoniae field isolates.

Authors:  J Vicca; T Stakenborg; D Maes; P Butaye; J Peeters; A de Kruif; F Haesebrouck
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

2.  Comparative susceptibilities of various animal-pathogenic mycoplasmas to fluoroquinolones.

Authors:  P C Hannan; G D Windsor; A de Jong; N Schmeer; M Stegemann
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

3.  Susceptibilities of Mycoplasma fermentans and Mycoplasma hyorhinis to membrane-active peptides and enrofloxacin in human tissue cell cultures.

Authors:  Ran Nir-Paz; Marie-Christine Prévost; Pierre Nicolas; Alain Blanchard; Henri Wróblewski
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

4.  Multilocus sequence typing of Mycoplasma hyorhinis strains identified by a real-time TaqMan PCR assay.

Authors:  Véronique Tocqueville; Séverine Ferré; Ngoc Hong Phuc Nguyen; Isabelle Kempf; Corinne Marois-Créhan
Journal:  J Clin Microbiol       Date:  2014-03-12       Impact factor: 5.948

5.  Antimicrobial susceptibility profiles of porcine mycoplasmas isolated from samples collected in southern Europe.

Authors:  Rubén S Rosales; Ana S Ramírez; María M Tavío; Carlos Poveda; José B Poveda
Journal:  BMC Vet Res       Date:  2020-09-03       Impact factor: 2.741

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.